BDC12-4.1 T-Cell Receptor Transgenic Insulin-Specific CD4 T Cells Are Resistant to In Vitro Differentiation into Functional Foxp3⁺ T Regulatory Cells

• Ghanashyam Sarikonda ,

  Contributed equally to this work with: Ghanashyam Sarikonda, Georgia Fousteri

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Georgia Fousteri ,

  Contributed equally to this work with: Ghanashyam Sarikonda, Georgia Fousteri

  Current address: San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Sowbarnika Sachithanantham,

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Jacqueline F. Miller,

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Amy Dave,

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Therese Juntti,

  Affiliation Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA

  ⨯
• Ken T. Coppieters,

  Affiliation Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA

  ⨯
• Matthias von Herrath

  * E-mail: matthias@liai.org

  Affiliations Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA, Type 1 Diabetes R&D center, Novo Nordisk Inc., Seattle, Washington, USA

  ⨯